For example, OL-1, an ASO targeting the APP mRNA region corresponding to the 17–30 amino acid fragment of Aβ [2], reduced APP expression in AD mouse models, including transgenic Tg2576 (APPswe) and SAMP8 mice. Here, APP is linked to Alzheimer disease.